Cargando…
Minimally invasive surgery and cancer: controversies part 1
Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and qua...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814196/ https://www.ncbi.nlm.nih.gov/pubmed/19572178 http://dx.doi.org/10.1007/s00464-009-0583-3 |
_version_ | 1782176985767739392 |
---|---|
author | Goldfarb, Melanie Brower, Steven Schwaitzberg, S. D. |
author_facet | Goldfarb, Melanie Brower, Steven Schwaitzberg, S. D. |
author_sort | Goldfarb, Melanie |
collection | PubMed |
description | Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro–con debate format. |
format | Text |
id | pubmed-2814196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-28141962010-02-13 Minimally invasive surgery and cancer: controversies part 1 Goldfarb, Melanie Brower, Steven Schwaitzberg, S. D. Surg Endosc Review Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro–con debate format. Springer-Verlag 2009-07-02 2010 /pmc/articles/PMC2814196/ /pubmed/19572178 http://dx.doi.org/10.1007/s00464-009-0583-3 Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Review Goldfarb, Melanie Brower, Steven Schwaitzberg, S. D. Minimally invasive surgery and cancer: controversies part 1 |
title | Minimally invasive surgery and cancer: controversies part 1 |
title_full | Minimally invasive surgery and cancer: controversies part 1 |
title_fullStr | Minimally invasive surgery and cancer: controversies part 1 |
title_full_unstemmed | Minimally invasive surgery and cancer: controversies part 1 |
title_short | Minimally invasive surgery and cancer: controversies part 1 |
title_sort | minimally invasive surgery and cancer: controversies part 1 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814196/ https://www.ncbi.nlm.nih.gov/pubmed/19572178 http://dx.doi.org/10.1007/s00464-009-0583-3 |
work_keys_str_mv | AT goldfarbmelanie minimallyinvasivesurgeryandcancercontroversiespart1 AT browersteven minimallyinvasivesurgeryandcancercontroversiespart1 AT schwaitzbergsd minimallyinvasivesurgeryandcancercontroversiespart1 |